Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: PPARG is a potential target of Tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics

Fig. 1

Anti-proliferation effects of Tanshinone IIA on LNCaP cells with transcriptomic analysis. A CCK-8 cell viability assay of LNCaP cells treated with 2.5 μg/ml Tanshinone IIA; B colony formation assay of LNCaP cells treated with 2.5 μg/ml Tanshinone IIA; C volcano plot of differentially expressed genes of LNCaP cells induced by 2.5 μg/ml Tanshinone IIA; D GO enrichment of differentially expressed genes; E. KEGG enrichment of LNCaP cells induced by 2.5 μg/ml Tanshinone IIA

Back to article page